The importance of the percentage of M2 macrophages of the total macrophage count (i.e. the CD163/CD68 ratio) and M1/M2 ratio has been found in other tumor types recently, such as melanoma, non-small cell lung carcinoma and angioimmunoblastic T-cell lymphoma [12]–[17]. Here, CD163 is linked to neoplasm.